Ranish Patel (@ranishpatelmd) 's Twitter Profile
Ranish Patel

@ranishpatelmd

General Surgery Resident @OHSUSurgery | @OHSUSOM ‘19 Alumn | #GoPackGo| #RCTID. Aspiring surgical oncologist 🦀

ID: 1134294013312266240

calendar_today31-05-2019 03:02:21

89 Tweet

193 Followers

220 Following

Flavio G Rocha, MD, FACS, FSSO (@flaviorochamd) 's Twitter Profile Photo

Thought-provoking talk 🗣️ #SSO2024 by @OHSUsurgery resident Ranish Patel on circulating hybrid cells🩸in #ColorectalCancer with OHSU Knight Cancer Institute Cancer Biology Co-Lead Dr. Melissa Wong. 🤔 applications for screening, treatment response, surveillance #ColorectalCancerAwarenessMonth

Thought-provoking talk 🗣️ #SSO2024 by @OHSUsurgery resident <a href="/RanishPatelMD/">Ranish Patel</a> on circulating hybrid cells🩸in #ColorectalCancer with <a href="/OHSUKnight/">OHSU Knight Cancer Institute</a> Cancer Biology Co-Lead Dr. Melissa Wong.

🤔 applications for screening, treatment response, surveillance

#ColorectalCancerAwarenessMonth
Skye C. Mayo, MD, MPH (@drymtn) 's Twitter Profile Photo

No Tweeter >1 yr & enjoyed it 😊. Congrats to @OHSUsurgery resident Issac Schwantes on Society of Surgical Oncology 🗣️ on OHSU Knight Cancer Institute Modified #HAI Dose Reduction. Only safe outcomes in ⬆️📈HAI centers will 🛑 repeating the history of HAI. Modified HAI FUDR dosing: it’s a marathon, not a sprint.

No Tweeter &gt;1 yr &amp; enjoyed it 😊. Congrats to @OHSUsurgery resident Issac Schwantes on <a href="/SocSurgOnc/">Society of Surgical Oncology</a> 🗣️ on <a href="/OHSUKnight/">OHSU Knight Cancer Institute</a> Modified #HAI Dose Reduction. Only safe outcomes in ⬆️📈HAI centers will 🛑 repeating the history of HAI. Modified HAI FUDR dosing: it’s a marathon, not a sprint.
Flavio G Rocha, MD, FACS, FSSO (@flaviorochamd) 's Twitter Profile Photo

Outstanding session IHPBA #CapeTown management of unresectable intrahepatic #cholangiocarcinoma Cholangiocarcinoma Foundation Skye C. Mayo, MD, MPH 🔑 points: 1) Optimal treatment sequencing 2) How best to control liver disease 3) Role of molecular profiling Kerri Lunsford Bas Groot Koerkamp

Outstanding session <a href="/IHPBA/">IHPBA</a> #CapeTown management of unresectable intrahepatic #cholangiocarcinoma <a href="/curecc/">Cholangiocarcinoma Foundation</a> <a href="/drymtn/">Skye C. Mayo, MD, MPH</a> 

🔑 points:

1) Optimal treatment sequencing
2) How best to control liver disease
3) Role of molecular profiling 

<a href="/KerriLunsford/">Kerri Lunsford</a> <a href="/BasGrootKoerkam/">Bas Groot Koerkamp</a>
Flavio G Rocha, MD, FACS, FSSO (@flaviorochamd) 's Twitter Profile Photo

Our response to Letter to the Editor on the role of the endoscopist in the treatment of pancreatic cancer We believe in multiD care of #PDAC @OHSUsurgery OHSU Knight Cancer Institute @OHSUpancreatic OHSU Gastroenterology & Hepatology Society of Surgical Oncology Annals of Surgical Oncology #precisiononcology #endcancer link.springer.com/article/10.124…

Flavio G Rocha, MD, FACS, FSSO (@flaviorochamd) 's Twitter Profile Photo

Kudos 👏🏽 Ranish Patel Patrick J. Worth, MD @OHSUsurgery OHSU Knight Cancer Institute @OHSUpancreatic🔥 off the press 📝 on rapid recurrence in 🔪 ✂️ 🪡 #PDAC ⬆️ risk: 1) Surgical site infxn 2) LN + Adjuvant but not neoadjuvant tx protective IHPBA @HPBjournal PanCAN sciencedirect.com/science/articl…

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

New study from Flavio G Rocha, MD, FACS, FSSO Patrick J. Worth, MD & colleagues at OHSU Knight Cancer Institute Rapid metastatic recurrence after #PancreaticCancer resection: a multi-center, regional analysis of trends in surgical failure over two decades Approximately ~25% of patients who undergo surgery recur

New study from <a href="/FlavioRochaMD/">Flavio G Rocha, MD, FACS, FSSO</a> <a href="/PatrickJWorth/">Patrick J. Worth, MD</a> &amp; colleagues at <a href="/OHSUKnight/">OHSU Knight Cancer Institute</a> 
Rapid metastatic recurrence after #PancreaticCancer resection: a multi-center, regional analysis of trends in surgical failure over two decades
Approximately ~25% of patients who undergo surgery recur
OHSU Knight Cancer Institute (@ohsuknight) 's Twitter Profile Photo

Researchers at OHSU News have developed a test, which uses a small blood sample to detect changes in protease activity — a key indicator of pancreatic ductal adenocarcinoma, the most common and deadly form of #PancreaticCancer. #OHSUResearch: bit.ly/3EKoBWu

Science Translational Medicine (@sciencetm) 's Twitter Profile Photo

A new liquid biopsy assay named PAC-MANN detects protease activity in blood samples to distinguish #PancreaticCancer with promising sensitivity and specificity for early-stage tumors in a clinical study. Jared Fischer OHSU Knight Cancer Institute scim.ag/41e1fBB

A new liquid biopsy assay named PAC-MANN detects protease activity in blood samples to distinguish #PancreaticCancer with promising sensitivity and specificity for early-stage tumors in a clinical study. <a href="/fischerjm/">Jared Fischer</a> <a href="/OHSUKnight/">OHSU Knight Cancer Institute</a> scim.ag/41e1fBB